Quarterly ResultAug 11, 2026, 04:19 PM
Sanara MedTech Q2 Revenue $28.1M, Net Loss $0.4M
AI Summary
Sanara MedTech Inc. reported its second quarter 2026 financial results, with net revenue increasing 9% to $28.1 million and gross profit growing 10% to $26.2 million. Despite revenue growth, the company posted a net loss from continuing operations of $0.4 million for the quarter, compared to net income in the prior year, primarily due to higher operating expenses and interest. Adjusted EBITDA saw a modest increase to $5.0 million. Management also highlighted the recently announced agreement for Sanara to be acquired by MIMEDX, which is expected to combine their surgical portfolios.
Key Highlights
- Net revenue increased 9% to $28.1 million in Q2 2026 compared to Q2 2025.
- Gross profit rose 10% to $26.2 million, representing 93% of net revenue in Q2 2026.
- Reported a net loss from continuing operations of $0.4 million, or $0.05 per diluted share in Q2 2026.
- Adjusted EBITDA increased to $5.0 million in Q2 2026 from $4.7 million in Q2 2025.
- Net revenue for the first six months of 2026 increased 14% to $55.9 million.
- Adjusted EBITDA for the first six months of 2026 was $9.3 million, up from $7.4 million.
- Company announced expected acquisition by MIMEDX, pending customary closing conditions.
- Cash and cash equivalents were $15.4 million with $46.5 million long-term debt as of June 30, 2026.
Price Impact
More from SMTI